TESAMORELIN

Tesamorelin is a synthetic peptide that mimics Growth Hormone-Releasing Hormone (GHRH), stimulating the body’s natural production and release of growth hormone. AH-Clinics utilizes Tesamorelin primarily to address excess visceral fat, particularly in individuals with lipodystrophy. By promoting the reduction of visceral adipose tissue, Tesamorelin can contribute to improved metabolic health and body composition, offering a targeted approach to fat management.

POTENTIAL BENEFITS: Reduces visceral fat (fat around internal organs); Stimulates natural growth hormone production; May improve lipid profiles and cardiovascular health; Can enhance body composition; Supports overall metabolic health.

INGREDIENTS: Tesamorelin, a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH).